HRA Pharma Prepares Observational Post-Approval Study of Ketoconazole
News
After receiving the approval of ketoconazole for the treatment of Cushing’s syndrome patients in the European Union, HRA Pharma is setting up to conduct a post-approval observation study that ... Read more